These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25908502)

  • 1. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.
    Rahbari NN; Biondo S; Frago R; Feißt M; Kreisler E; Rossion I; Serrano M; Jäger D; Lehmann M; Sommer F; Dignass A; Bolling C; Vogel I; Bork U; Büchler MW; Folprecht G; Kieser M; Lordick F; Weitz J;
    J Clin Oncol; 2024 May; 42(13):1531-1541. PubMed ID: 38412408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of primary tumor resection for asymptomatic colorectal cancer patients with unresectable metastases: a systematic review and meta-analysis.
    Li S; Ji L; Huang J; Wang Y; Liu P; Zhang W; Lou Z
    Int J Colorectal Dis; 2023 Aug; 38(1):214. PubMed ID: 37581775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial.
    Lin Q; Ding K; Zhao R; Wang H; Wei Y; Ren L; Ye Q; Cui Y; He G; Tang W; Feng Q; Zhu D; Chang W; Wang X; Liang L; Zhou G; Liang F; Ye F; Wang J; Fan J; Xu J
    Eur J Cancer; 2023 Sep; 191():112961. PubMed ID: 37473466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinous Adenocarcinoma With Liver Metastasis.
    Liao SW; Zhan JQ; Liu CT; Yu HT; Wen MJ
    Am J Clin Oncol; 2024 Jan; 47(1):30-39. PubMed ID: 38148710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis.
    Maroney S; de Paz CC; Reeves ME; Garberoglio C; Raskin E; Senthil M; Namm JP; Solomon N
    J Gastrointest Surg; 2018 Mar; 22(3):460-466. PubMed ID: 29124549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience.
    Moretto R; Germani MM; Borelli B; Conca V; Rossini D; Boraschi P; Donati F; Urbani L; Lonardi S; Bergamo F; Cerma K; Ramondo G; D'Amico FE; Salvatore L; Valente G; Barbaro B; Giuliante F; Di Maio M; Masi G; Cremolini C
    ESMO Open; 2024 Apr; 9(4):102991. PubMed ID: 38631269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Tumor Resection Plus Chemotherapy versus Chemotherapy Alone for Colorectal Cancer Patients with Synchronous Bone Metastasis.
    Li Y; Cheng X; Zhong C; Yuan Y
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629673
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV colorectal cancer: a survival analysis.
    Tsang WY; Ziogas A; Lin BS; Seery TE; Karnes W; Stamos MJ; Zell JA
    J Gastrointest Surg; 2014 Mar; 18(3):592-8. PubMed ID: 24297651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.
    de Mestier L; Manceau G; Neuzillet C; Bachet JB; Spano JP; Kianmanesh R; Vaillant JC; Bouché O; Hannoun L; Karoui M
    World J Gastrointest Oncol; 2014 Jun; 6(6):156-69. PubMed ID: 24936226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of patients with unresectable stage IV Colon cancer undergoing primary tumor resection: A multicenter study of minimally symptomatic or asymptomatic primary tumor.
    Ho MF; Lai VC; Ng DCK; Ng SSM
    Asian J Surg; 2023 Sep; 46(9):3710-3715. PubMed ID: 36522225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.
    Poultsides GA; Servais EL; Saltz LB; Patil S; Kemeny NE; Guillem JG; Weiser M; Temple LK; Wong WD; Paty PB
    J Clin Oncol; 2009 Jul; 27(20):3379-84. PubMed ID: 19487380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of liver-directed therapy in colorectal cancer liver metastases.
    Vargas GM; Parmar AD; Sheffield KM; Tamirisa NP; Brown KM; Riall TS
    J Surg Res; 2014 Sep; 191(1):42-50. PubMed ID: 24990539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
    Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
    BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.
    van der Kruijssen DEW; Elias SG; van de Ven PM; van Rooijen KL; Lam-Boer J'; Mol L; Punt CJA; Sommeijer DW; Tanis PJ; Nielsen JD; Yilmaz MK; van Riel JMGH; Wasowiz-Kemps DK; Loosveld OJL; van der Schelling GP; de Groot JWB; van Westreenen HL; Jakobsen HL; Fromm AL; Hamberg P; Verseveld M; Jaensch C; Liposits GI; van Duijvendijk P; Oulad Hadj J; van der Hoeven JAB; Trajkovic M; de Wilt JHW; Koopman M;
    Ann Oncol; 2024 Jun; ():. PubMed ID: 38852675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for conversion hepatectomy for initially unresectable colorectal cancer with liver metastasis.
    Sugiyama M; Uehara H; Shin Y; Shiokawa K; Fujimoto Y; Mano Y; Komoda M; Nakashima Y; Sugimachi K; Yamamoto M; Morita M; Toh Y
    Surg Today; 2022 Apr; 52(4):633-642. PubMed ID: 34762175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer.
    Shin JE; An HJ; Shim BY; Kim H; Park HS; Cho HM; Kye BH; Yoo RN; Moon JY; Kim SH; Lee J; Lee HC; Jung JH; Lee KM; Lee JM
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of derived neutrophil-to-lymphocyte ratio after four weeks predicts the outcome of patients receiving second-line chemotherapy for metastatic colorectal cancer.
    Colloca GA; Venturino A; Guarneri D
    Cancer Immunol Immunother; 2021 Apr; 70(4):1115-1125. PubMed ID: 33123753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the Addition of Biologic Agents to Chemotherapy in Patients with Unresectable Colorectal Cancer Metastases Result in a Higher Proportion of Patients Undergoing Resection? A Systematic Review and Meta-analysis.
    Bogach J; Levine O; Parpia S; Valencia M; Ruo L; Serrano P
    J Gastrointest Surg; 2018 Mar; 22(3):523-528. PubMed ID: 29204907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
    Ergun Y; Bal O; Dogan M; Ucar G; Dirikoc M; Acikgoz Y; Bacaksiz F; Uncu D
    J Res Med Sci; 2020; 25():14. PubMed ID: 32174986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.